A detailed history of Cascade Investment Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Cascade Investment Advisors, Inc. holds 11,915 shares of ZTS stock, worth $1.42 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
11,915
Holding current value
$1.42 Million
% of portfolio
0.87%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 14, 2026

BUY
$118.8 - $147.53 $1.42 Million - $1.76 Million
11,915 New
11,915 $1.42 Million
Q1 2023

May 10, 2023

BUY
$145.48 - $175.02 $5,091 - $6,125
35 New
35 $5,000
Q1 2022

Apr 11, 2022

BUY
$181.39 - $234.03 $6,348 - $8,191
35 New
35 $6,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $55.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cascade Investment Advisors, Inc. Portfolio

Follow Cascade Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.